News
Cancer cell lines predict drug response, study shows
- Author:
- HT Staff
Image from PNAS A study published in Cell has shown that patient-derived cancer cell lines harbor most of the same genetic changes found in...
News
Mutations may be a ‘missing link’ in AML
- Author:
- HT Staff
Research published in Nature Communications suggests that mutations in the ZBTB7A gene are associated with t(8;21)-rearranged acute myeloid...
News
Material can dissolve blood clots more efficiently, team says
- Author:
- HT Staff
Image by Kevin MacKenzie Researchers say they have developed a thrombolytic material that can be condensed on a blood clot by means of a magnetic...
News
NICE recommends approval for bosutinib
- Author:
- HT Staff
Photo courtesy of CDC The National Institute for Health and Care Excellence (NICE) has issued a final draft guidance recommending approval for...
News
NHL patients may have higher risk of second cancer
- Author:
- HT Staff
Photo courtesy of NIH Compared to patients with other common cancers, patients with non-Hodgkin lymphoma (NHL) have a higher risk of developing a...
News
Results support INR self-monitoring/management
- Author:
- HT Staff
Results of a systematic review support self-monitoring and self-management for patients on long-term oral anticoagulation therapy. Researchers...
News
Study reveals global variations of P vivax
- Author:
- HT Staff
from patients in Thailand Image by Wanlapa Roobsoong Researchers say they have uncovered the global, evolving, and historic make-up of the...
News
EC extends marketing authorization for brentuximab vedotin
- Author:
- HT Staff
Photo from Business Wire The European Commission (EC) has extended the current conditional marketing authorization of brentuximab vedotin (...
News
Drugs produce comparable results in CP-CML
- Author:
- HT Staff
Long-term results from the DASISION trial suggest that dasatinib and imatinib produce similar outcomes in patients with newly diagnosed chronic...
News
EC expands approved use of carfilzomib
- Author:
- HT Staff
Photo from Amgen The European Commission (EC) has expanded the approved use of the proteasome inhibitor carfilzomib (Kyprolis). The drug is now...
News
How multiple infections make malaria worse
- Author:
- HT Staff
Image by Ute Frevert and Margaret Shear New research suggests that infections with 2 types of malaria parasite lead to greater health risks...
News
Study explains link between malignant hyperthermia and bleeding abnormalities
- Author:
- HT Staff
A new study helps explain why some patients with malignant hyperthermia may suffer from excessive bleeding. The findings suggest a mutation that...
News
Team identifies potential therapeutic target for AML
- Author:
- HT Staff
New research suggests that E proteins and their antagonists, Id proteins, can play key roles in acute myeloid leukemia (AML). The study showed...
News
Study reveals SNPs that may increase risk of MM
- Author:
- HT Staff
A large study has revealed several genetic variations that may increase a person’s risk of developing multiple myeloma (MM). The findings,...
News
Efficacy of malaria vaccine declines over time
- Author:
- HT Staff
Photo by Caitlin Kleiboer Results from a phase 2 study of the malaria vaccine RTS,S (also known as RTS,S/AS01 or Mosquirix) suggest its efficacy...